MDMA的药理动力学:一个基于人群和生理学的药理动力学模型的分析
Marilyn A Huestis1, William B Smith2, Cathrine Leonowens3
1Institute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
米多玛胺 (MDMA) 的药理动力学不会受到食物的显著影响. 虽然MDMA是一种强大的CYP2D6抑制剂,但它不太可能影响对运输器敏感的药物.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物新陈代谢 药物新陈代谢
- 临床药理学 临床药理学
背景情况:
- 米多玛胺 (MDMA) 正在FDA审查中,用于PTSD治疗.
- MDMA通过CYP2D6代谢,并抑制了CYP2D6,MATE1,OCT1和OCT2.
- 了解MDMA的药理动力学对于安全有效的临床使用至关重要.
研究的目的:
- 为了评估食物对MDMA药理动学的影响.
- 开发和验证MDMA的群体药动力学 (PopPK) 和生理学基础的药动力学 (PBPK) 模型.
- 为了预测临床剂量方案的药物相互作用 (DDI) 和药理动力学.
主要方法:
- 一个药理动力学I期研究评估了食物的影响.
- 使用研究数据,已发表的数据和体外数据开发和验证了PopPK和PBPK模型.
- 在PBPK模拟中,研究了食物的影响,剂量方案和DDI.
主要成果:
- 高脂肪的食物没有改变MDMA的血度,但延迟了Tmax.
- 在PopPK分析中,没有发现具有临床意义的共变量.
- PBPK模型预测了单剂量与分剂量的轻微暴露差异,分剂量的延迟Tmax.
- MDMA是一种强大的CYP2D6抑制剂,对脏输送基质的预测影响最小.
结论:
- 食物不会显著改变MDMA的药理动力学.
- 在临床剂量范围内,MDMA的药理动力学概况是可预测的.
- 虽然MDMA是一种强大的CYP2D6抑制剂,但不太可能通过运输体引起临床相关的DDI.
更多相关视频
08:59An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
07:31Author Spotlight: Advancing Cell Membrane Biophysics - Exploring Interactions and Challenges Through Experimental and Computational Approaches
Published on: September 1, 2023
相关概念视频
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Mechanistic Models: Overview of Compartment Models
